Navigation Links
Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Date:10/18/2010

PLANTATION, Fla., Oct. 18 /PRNewswire/ -- Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.  This product will be manufactured under cGMP conditions as a kit for radio-labeling for use in clinical trials. Terms of the manufacturing agreement were not disclosed.

"This project will allow us to utilize our extensive experience and expertise in bio-conjugation technologies that we have honed over the last few years" said Muctarr Sesay, Ph. D., Vice President of Process Development at Goodwin Biotechnology. "We have had great history in developing and producing antibody-drug conjugates for diagnostic imaging and therapeutics, and this project is already underway with excellent progress.

"We have recently seen a strong interest in bio-conjugations from the biopharmaceutical industry to develop improved imaging and therapeutic biologic compounds," commented SooYoung Lee, Ph.D. Sr. Vice President of Operations. "Along with bio-conjugations, monoclonal antibody and recombinant therapeutic protein process development and cGMP manufacturing have become Goodwin's core competencies." "Most of our customers are looking for one stop shop type of CMO services that will provide development, bulk production, characterization and fill/finish at one location" said Dr. Lee.. "This client realizes the value in these combined services, and we expect a long-term relationship to grow out of this initial project with them. I believe they have a partner in Goodwin that will provide the excellent technology, time and cost management that is difficult to find".

About Goodwin Biotechnology, Inc.Goodwin Biotechnology Inc., (GBI) located in Plantation, FL., is a full service contract biomanufacturing company and specializes in process development and cGMP production of protein based therapeutics and bio-conjugations for pre-clinical and early phase clinical trials. The products manufactured by GBI are being used in clinical trials and the Company has assisted in the preparation of many IND filings for various clients during the past few years. GBI caters to all pharmaceutical and biotech organizations, including large multinationals, small to midsize biotech companies, universities, cancer research institutes and various branches of the U.S. Government.For more information, please contact:Goodwin Biotechnology Inc.(954) 327-9634info@goodwinbio.com
'/>"/>

SOURCE Goodwin Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has ... and Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Electrodes Market is poised to grow at a CAGR of around ... the market is witnessing include advancements in extracellular microelectrode arrays and ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... 8. Dezember 2016 Mederi Therapeutics Inc . hat die behördliche ... Behandlungsmethode für gastroösophageale Refluxerkrankung (GERD) – in China ... ... Live Stretta procedure performed and ... Director of Endoscopy at Wuhan Union Hospital ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... ... “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health ... . , Results of the comparative usability study demonstrate that a dictation-based method ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , ... and other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger ... vice president of sales. , Litsinger joined Mirixa in 2008 after serving ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for ... In Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues ... implant and prosthetic market in the U.S. is projected to reach $6.4 billion in ...
(Date:12/8/2016)... ... , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced ... program, at their world headquarters of Omni La Costa Resort & Spa in San ... seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. The ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
Breaking Medicine News(10 mins):